07.27.20 -- Choosing The Best Sterile Dosage Forms For Your Phase I Clinical Supply Needs

When developing a parenteral product, pharmaceutical scientists are faced with a variety of choices — choices that can be conflicting or present differing advantages.

Biologics, orphan drugs, and precision medicine are on the rise, and that means some big changes for drug development and manufacturing companies.

Take a look inside this sterile fill-finish manufacturing site in Monza, Italy. This state-of-the-art facility is a center of excellence for sterile injectables development. All manufacturing services are fully supported with comprehensive in-house analytical and bioanalytical capabilities.